Medical Article

Ensuring buy-in from end users is critical to hospitals’ AI success. To achieve buy-in, hospitals should start by adopting AI tools that address the problems that physicians and nurses have identified as most important to them, said Rohit Chandra, chief digital officer at Cleveland Clinic. The post Cleveland Clinic Digital Chief: Pick AI Problems That…

Fujirebio Diagnostics’ blood test for Alzheimer’s disease offers a less expensive and less invasive alternative compared to medical imaging and tests of cerebrospinal fluid. But competition looms from blood-based tests in development by other diagnostics companies. The post Alzheimer’s Disease Now Has Its First FDA-Cleared Blood Test appeared first on MedCity News.

WeightWatchers recently filed for bankruptcy. Part of the reason is because it couldn’t adapt fast enough to a rapidly changing weight-loss environment spurred by the rising popularity of GLP-1s, experts said. The post Why WeightWatchers Filed for Bankruptcy appeared first on MedCity News.

As the safety-net landscape shifts and funding uncertainty grows, the path forward is clear. By investing in highly coordinated, data-informed care and aligning health plans, providers and communities around shared goals, we can build a system that reaches individuals with complex care needs, supports whole-person health initiatives and strengthens care across the board. The post…

As demand for trial sites increases, more investigators are overburdened or experiencing burnout. What can the industry do to help? The post Clinical Trials Have a Research Site Demand and Supply Crisis. Here is How to Solve it appeared first on MedCity News.

Without trust, the rapid adoption of AI in healthcare could stall, pointed out Joel Gordon, UW Health’s chief medical information officer. He urged healthcare leaders to focus less on flashy rollouts and more on governance, collaboration, and meaningful metrics to ensure AI delivers lasting value. The post Don’t Let the Floor Fall Out From Under…

Sprinter Health’s $55 million Series B round was led by General Catalyst and included participation from Andreessen Horowitz (a16z) Bio + Health, the Regents of the University of California, Google Ventures and Accel. The post Sprinter Health Raises $55M to Expand Home Health Services for Health Plans appeared first on MedCity News.

Inozyme Pharma’s main asset is in pivotal testing in children who have a rare enzyme deficiency that affects bones and blood vessels. BioMarin Pharmaceutical, already well established in enzyme replacement, said it will use its experience and infrastructure to grow the market for this product, potentially for several indications. The post BioMarin’s $270M Inozyme Acquisition…